How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation()

The COVID-19 pandemic has shown itself to be an unprecedented challenge for vaccines which are widely recognized as the most important tool to exit this pandemic. We have witnessed vaccine scientists, developers, manufacturers, and stakeholders deliver several vaccines in just about a year. This is...

Descripción completa

Detalles Bibliográficos
Autores principales: McGoldrick, Mic, Gastineau, Thierry, Wilkinson, Diane, Campa, Cristiana, Clercq, Norbert De, Mallia-Milanes, Andrea, Germay, Olivier, Krishnan, Jyothsna, Van Ooij, M., Thien, Michael P., Mlynarczyk, Peter J., Saltus, Edward, Juvin, Philippe, Clenet, Didier, Basso, Ana, Dellepiane, Nora, Pagliusi, Sonia, de Moraes Stávale, Monique Collaço, Sivaramakrishnan, Venkatraman H., Desai, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846260/
https://www.ncbi.nlm.nih.gov/pubmed/35180993
http://dx.doi.org/10.1016/j.vaccine.2021.11.098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846260/
https://www.ncbi.nlm.nih.gov/pubmed/35180993
http://dx.doi.org/10.1016/j.vaccine.2021.11.098

Ejemplares similares